Enfermedades infecciosas y microbiologia clinica最新文献

{"title":"RIME sine rash asociada a infección por Mycoplasma pneumoniae","authors":"Antonio Bustos-Merlo, Ana Peragón-Ortega, Antonio Rosales-Castillo, Pedro Alberto Alarcón-Blanco","doi":"10.1016/j.eimc.2024.10.004","DOIUrl":"10.1016/j.eimc.2024.10.004","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 3","pages":"Pages 180-181"},"PeriodicalIF":2.6,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143526683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Complicated malaria caused by Plasmodium falciparum with parasitemia >50%","authors":"Miguel Morante-Ruiz, Cristina Ortega-Portas, Luis José Betancourt-Cuadra, Miguel Górgolas Hernández-Mora","doi":"10.1016/j.eimc.2024.07.006","DOIUrl":"10.1016/j.eimc.2024.07.006","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 3","pages":"Pages 175-176"},"PeriodicalIF":2.6,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143527286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Seroprevalence status of vaccine-preventable diseases in migrants living in shelter centers in Barcelona, Spain","authors":"Carles Rubio Maturana ,&nbsp;Marta Guerrero ,&nbsp;Maria Casas Claramunt ,&nbsp;Susana Nuria Ayala-Cortés ,&nbsp;Victoria López ,&nbsp;Patricia Martínez-Vallejo ,&nbsp;Begoña Treviño ,&nbsp;Elena Sulleiro ,&nbsp;Juliana Esperalba ,&nbsp;Ariadna Rando ,&nbsp;Diana Pou ,&nbsp;Maria Luisa Aznar ,&nbsp;Pau Bosch-Nicolau ,&nbsp;Fernando Salvador ,&nbsp;Inés Oliveira-Souto ,&nbsp;Israel Molina ,&nbsp;Núria Serre-Delcor","doi":"10.1016/j.eimc.2024.04.005","DOIUrl":"10.1016/j.eimc.2024.04.005","url":null,"abstract":"<div><h3>Introduction</h3><div>Almost 281 million people were living in a foreign country in 2022, and more than 100 million were displaced because of war conflicts and human right violations. Vaccination coverage of infectious diseases in migrants from some disadvantaged settings could be lower than reception countries populations, consequently seroprevalence studies and better access to vaccination could contribute to reducing these differences.</div></div><div><h3>Methods</h3><div>A descriptive retrospective cross-sectional study was conducted including migrants, living ≤5 years in the reception country and ≥16 years old, who requested a medical exam between January 1st, 2020 and January 31st, 2021. Seroprevalence assessment was performed, and vaccination was offered to those individuals without immunity to hepatitis B, hepatitis A, varicella, measles, mumps, and rubella.</div></div><div><h3>Results</h3><div>A total of 315 migrants were attended during the study period. Immunity protection at arrival was 252/296 (85.1%) for measles, 274/295 (92.9%) for rubella, 257/296 (86.8%) for mumps, 264/295 (89.5%) for varicella, 267/313 (85.3%) for hepatitis A, and 104/300 (34.6%) for hepatitis B. The final immunity protection after full vaccination schedules was 278/296 (93.9%) for measles, 287/295 (97.3%) for rubella, 274/296 (92.6%) for mumps, 276/295 (93.6%) for varicella, 280/313 (89.5%) for hepatitis A, and 139/300 (46.3%) for hepatitis B.</div></div><div><h3>Conclusions</h3><div>The vaccination intervention has increased immunity rates for the studied diseases in the attended migrants in our center, however, such interventions should be maintained to reach local population immunization levels. Moreover, the collaboration between shelter and reference specialized health centers is fundamental to implement such vaccination programs.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 3","pages":"Pages 139-147"},"PeriodicalIF":2.6,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141137887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Estudio prospectivo para la detección precoz de carcinoma pulmonar en pacientes con infección por VIH (estudio GESIDA 8815)","authors":"M. Eulalia Valencia ,&nbsp;Tatiana Pirogova ,&nbsp;Delia Romera ,&nbsp;Marta Montero ,&nbsp;María Tasías ,&nbsp;José Sanz ,&nbsp;Alberto Arranz ,&nbsp;Jorge Vergas ,&nbsp;M. Jesús Tellez ,&nbsp;Francisco Fanjul ,&nbsp;Antoni Campins ,&nbsp;Miguel Cervero ,&nbsp;Inmaculada Jarrín ,&nbsp;Marta de Miguel ,&nbsp;Luz Martín Carbonero ,&nbsp;María Yllescas ,&nbsp;Juan González","doi":"10.1016/j.eimc.2024.03.003","DOIUrl":"10.1016/j.eimc.2024.03.003","url":null,"abstract":"<div><h3>Introduction</h3><div>Lung cancer (LC) screening detects tumors early. The prospective GESIDA 8815 study was designed to assess the usefulness of this strategy in HIV+ people (PLHIV) by performing a low-radiation computed tomography (CT) scan.</div></div><div><h3>Patients and methods</h3><div>371 heavy smokers patients were included (&gt;<!--> <!-->20 packs/year), &gt;<!--> <!-->45<!--> <!-->years old and with a CD4+ &lt;<!--> <!-->200<!--> <!-->mm³ nadir. One visit and CT scan were performed at baseline and 4 for follow-up time annually.</div></div><div><h3>Results</h3><div>329 patients underwent the baseline visit and CT (CT0) and 206 completed the study (CT1<!--> <!-->=<!--> <!-->285; CT2<!--> <!-->=<!--> <!-->259; CT3<!--> <!-->=<!--> <!-->232; CT4<!--> <!-->=<!--> <!-->206). All were receiving ART. A total &gt;<!--> <!-->8<!--> <!-->mm lung nodules were detected, and 9 early-stage PCs were diagnosed (4 on CT1, 2 on CT2, 1 on CT3 and 2 on CT4). There were no differences between those who developed LC and those who did not in sex, age, CD4+ nadir, previous lung disease, family history, or amount of packets/year. At each visit, other pathologies were diagnosed, mainly COPD, calcified coronary artery and residual tuberculosis lesions. At the end of the study, 38 patients quit smoking and 75 reduced their consumption. Two patients died from LC and 16 from other causes (<em>P</em> <!-->=<!--> <!-->.025).</div></div><div><h3>Conclusions</h3><div>The design of the present study did not allow us to define the real usefulness of the strategy. Adherence to the test progressively decreased over time. The diagnosis of other thoracic pathologies is very frequent. Including smokers in an early diagnosis protocol for LC could help to quit smoking.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 3","pages":"Pages 125-132"},"PeriodicalIF":2.6,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143527084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnosis of Carrion's disease: A systematic review in South American countries and meta-analysis","authors":"Mauro A.F. Guimarães ,&nbsp;Laura A. Xavier ,&nbsp;Alice F. Silva ,&nbsp;Felipe C.M. Iani ,&nbsp;Cecília M.M. Anjos ,&nbsp;Cristiane F.O. Scarponi","doi":"10.1016/j.eimc.2024.11.005","DOIUrl":"10.1016/j.eimc.2024.11.005","url":null,"abstract":"<div><div><em>Bartonella bacilliformis</em> can cause a potentially fatal infection, Carrion's disease. This review synthesized data on the prevalence of this bacterial infection in South American countries. A comprehensive literature search relevant articles (published between 2010 and 2022) was conducted in four databases. Full texts were selected based on PECOTS eligibility and JBI methodological quality. The pooled bacterial infection rate was calculated using a random-effects meta-analysis model. Subgroup and meta-regression analyses were used to investigate statistical heterogeneity. Five studies (covering 717 individuals from Peru and Ecuador) were eligible for meta-analysis. The percentage of seropositive IgG antibodies against <em>B. bacilliformis</em> was 28.21% (95% CI: 6.29–33.39) among healthy Ecuadorian children. In Peru, the pooled bacterial detection rate in symptomatic individuals was 15.60% (95% CI: 4.24–31.98), using molecular tests. Carrion's disease is endemic in the Andean valleys, but a gradual reduction in infection rates among acute febrile patients in Peru has been observed in recent years. Laboratory diagnosis of this infection continues to be neglected in other South American countries. Public managers must plan effective arrangements in primary care services, integrating various technological levels to ensure comprehensive health care.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 3","pages":"Pages 165-171"},"PeriodicalIF":2.6,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143527088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Enfermedad de Chagas y coinfección por el VIH","authors":"Jesús Fernández Plaza ,&nbsp;Javier Guzmán ,&nbsp;Sandra Chamorro-Tojeiro ,&nbsp;José A. Pérez-Molina","doi":"10.1016/j.eimc.2024.09.008","DOIUrl":"10.1016/j.eimc.2024.09.008","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 2","pages":"Pages 117-119"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143135114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Análisis del diagnóstico serológico de la sífilis: una propuesta de mejora","authors":"Javier Gutiérrez Ballesteros ,&nbsp;Sonsoles Garcinuño Pérez ,&nbsp;Marta Domínguez-Gil González ,&nbsp;Silvia Rojo Rello","doi":"10.1016/j.eimc.2024.09.010","DOIUrl":"10.1016/j.eimc.2024.09.010","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 2","pages":"Pages 119-120"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143135115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dalbavancin as sequential therapy in infective endocarditis: Real-life experience in elder and comorbid patients","authors":"Eduardo Aparicio-Minguijón ,&nbsp;Jorge Boán ,&nbsp;Antonio Terrón ,&nbsp;Carlos Heredia ,&nbsp;Cristina Puente ,&nbsp;Asunción Pérez-Jacoiste Asín ,&nbsp;M. Ángeles Orellana ,&nbsp;Laura Domínguez ,&nbsp;José Manuel Caro ,&nbsp;M. Jesús López-Gude ,&nbsp;Eva María Aguilar-Blanco ,&nbsp;Andrea Eixerés-Esteve ,&nbsp;Francisco López-Medrano","doi":"10.1016/j.eimc.2024.04.009","DOIUrl":"10.1016/j.eimc.2024.04.009","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to evaluate the effectiveness of dalbavancin as sequential therapy in patients with infective endocarditis (IE) due to gram positive bacteria (GPB) in a real-life heterogenous cohort with comorbid patients.</div></div><div><h3>Methods</h3><div>A single center retrospective cohort study including all patients with definite IE treated with dalbavancin between January 2017 and February 2022 was developed. A 6-month follow-up was performed. The main outcomes were clinical cure rate, clinical and microbiological relapse, 6-month mortality, and adverse effects (AEs) rate.</div></div><div><h3>Results</h3><div>The study included 61 IE episodes. The median age was 78.5 years (interquartile range [IQR] 63.2–85.2), 78.7% were male, with a median Charlson comorbidity index of 7 (IQR 4–9) points. Overall, 49.2% suffered native valve IE. The most common microorganism was <span><span>Staphylococcus aureus</span></span> (26.3%) followed by <span><span>Enterococcus faecalis</span></span> (21.3%). The median duration of initial antimicrobial therapy and dalbavancin therapy were 27 (IQR 20–34) and 14 days (IQR 14–28) respectively. The total reduction of hospitalization was 1090 days. The most frequent dosage was 1500<!--> <!-->mg of dalbavancin every 14 days (96.7%). An AE was detected in 8.2% of patients, only one (1.6%) was attributed to dalbavancin (infusion reaction). Clinical cure was achieved in 86.9% of patients. One patient (1.6%) with <em>Enterococcus faecalis</em> IE suffered relapse. The 6-month mortality was 11.5%, with only one IE-related death (1.6%).</div></div><div><h3>Conclusion</h3><div>This study shows a high efficacy of dalbavancin in a heterogeneous real-world cohort of IE patients, with an excellent safety profile. Dalbavancin allowed a substantial reduction of in-hospital length of stay.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 2","pages":"Pages 86-92"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141415987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Peritonitis bacteriana aguda por Staphylococcus lugdunensis resistente a meticilina","authors":"David Roa Alonso ,&nbsp;Víctor Antón Berenguer ,&nbsp;Alberto Orejas Gallego ,&nbsp;Ricardo Díaz Abad","doi":"10.1016/j.eimc.2024.08.010","DOIUrl":"10.1016/j.eimc.2024.08.010","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 2","pages":"Pages 115-116"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143135113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Nuevo secuenciotipo ST6423 de Klebsiella pneumoniae hipervirulenta portador de carbapenemasa OXA-48-like causante de bacteriemia en un paciente inmunocomprometido","authors":"Carmen Palacios Clar,&nbsp;Diego García Martínez de Artola,&nbsp;Julia Alcoba Flórez","doi":"10.1016/j.eimc.2024.08.014","DOIUrl":"10.1016/j.eimc.2024.08.014","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 2","pages":"Pages 116-117"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143165732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}